https://www.medday-pharma.com/2020/03/10/medday-reports-top-line-data-from-phase-iii-trial-spi2-for-treatment-of-progressive-forms-of-multiple-sclerosis/
MedDay Reports Top-Line Data from Phase III Trial “SPI2” for Treatment of Progressive Forms of Multiple Sclerosis
